IL101622A - Pharmaceutical preparations containing fibrous calcitonin - Google Patents

Pharmaceutical preparations containing fibrous calcitonin

Info

Publication number
IL101622A
IL101622A IL10162292A IL10162292A IL101622A IL 101622 A IL101622 A IL 101622A IL 10162292 A IL10162292 A IL 10162292A IL 10162292 A IL10162292 A IL 10162292A IL 101622 A IL101622 A IL 101622A
Authority
IL
Israel
Prior art keywords
calcitonin
fibrillated
fibrils
hct
fragmented
Prior art date
Application number
IL10162292A
Other languages
English (en)
Hebrew (he)
Other versions
IL101622A0 (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL101622A0 publication Critical patent/IL101622A0/xx
Publication of IL101622A publication Critical patent/IL101622A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
IL10162292A 1991-04-23 1992-04-16 Pharmaceutical preparations containing fibrous calcitonin IL101622A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919108634A GB9108634D0 (en) 1991-04-23 1991-04-23 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
IL101622A0 IL101622A0 (en) 1992-12-30
IL101622A true IL101622A (en) 1996-06-18

Family

ID=10693744

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10162292A IL101622A (en) 1991-04-23 1992-04-16 Pharmaceutical preparations containing fibrous calcitonin

Country Status (19)

Country Link
US (1) US5593962A (pt)
EP (1) EP0510913B1 (pt)
JP (1) JP3532580B2 (pt)
KR (1) KR100245534B1 (pt)
AT (1) ATE194775T1 (pt)
AU (1) AU653395B2 (pt)
CA (1) CA2066532C (pt)
CY (1) CY2246B1 (pt)
DE (1) DE69231263T2 (pt)
DK (1) DK0510913T3 (pt)
ES (1) ES2150418T3 (pt)
GB (1) GB9108634D0 (pt)
GR (1) GR3034414T3 (pt)
IE (1) IE921278A1 (pt)
IL (1) IL101622A (pt)
MX (1) MX9201825A (pt)
NZ (1) NZ242440A (pt)
PT (1) PT510913E (pt)
ZA (1) ZA922899B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595760A (en) * 1994-09-02 1997-01-21 Delab Sustained release of peptides from pharmaceutical compositions
WO2000054797A2 (en) 1999-03-17 2000-09-21 Novartis Ag Pharmaceutical compositions comprising tgf-beta
CN1183965C (zh) 2000-02-04 2005-01-12 尤尼金实验室公司 鼻内降钙素制剂
RS52966B (en) * 2002-09-27 2014-02-28 Zentaris Gmbh FORM OF THE THERAPEUTIC APPLICATION OF ACTIVE PEPTIDES WITH THE LONG TERM RELEASE OF THE ACTIVE INGREDIENT
GB0422644D0 (en) * 2004-10-12 2004-11-10 Novartis Ag Organic compounds
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
US20110034385A1 (en) * 2008-04-07 2011-02-10 National Institute Of Immunology Compositions Useful for the Treatment of Diabetes and Other Chronic Disorder

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions

Also Published As

Publication number Publication date
AU1506692A (en) 1992-10-29
ES2150418T3 (es) 2000-12-01
ATE194775T1 (de) 2000-08-15
EP0510913A2 (en) 1992-10-28
CY2246B1 (en) 2003-07-04
JP3532580B2 (ja) 2004-05-31
IE921278A1 (en) 1992-11-04
DE69231263D1 (de) 2000-08-24
IL101622A0 (en) 1992-12-30
EP0510913B1 (en) 2000-07-19
MX9201825A (es) 1992-10-01
NZ242440A (en) 1993-10-26
JPH05139993A (ja) 1993-06-08
GB9108634D0 (en) 1991-06-12
AU653395B2 (en) 1994-09-29
US5593962A (en) 1997-01-14
DK0510913T3 (da) 2000-10-16
CA2066532A1 (en) 1992-10-24
DE69231263T2 (de) 2000-12-21
GR3034414T3 (en) 2000-12-29
EP0510913A3 (en) 1993-12-15
PT510913E (pt) 2000-12-29
CA2066532C (en) 2003-08-19
ZA922899B (en) 1993-10-22
KR100245534B1 (ko) 2000-03-02

Similar Documents

Publication Publication Date Title
EP1417972B2 (en) Stabilized teriparatide solutions
US7144861B2 (en) Stabilized teriparatide solutions
US5374620A (en) Growth-promoting composition and its use
JP3065662B2 (ja) 副甲状腺ホルモン製剤
RU2463040C2 (ru) Композиция и микросфера с контролируемым высвобождением экзендина и способ получения микросферы
JP2747073B2 (ja) ヒト成長ホルモン製剤
US5681814A (en) Formulated IGF-I Composition
EP1028746B1 (en) Method for producing igf-i sustained-release formulations
US20060074011A1 (en) Compositions providing for increased IGF-I solubility
JP2003525846A (ja) ヒトインスリン誘導体の集合体
JP2000504696A (ja) 安定化された成長ホルモン処方物およびその製造方法
EP0510913B1 (en) Pharmaceutical compositions comprising calcitonin
JPH08505617A (ja) インシュリン状成長因子を含有する安定溶液
JPH10507181A (ja) 成長ホルモンおよびバリンを含んでなる医薬製剤
IE83304B1 (en) Pharmaceutical compositions comprising calcitonin
JP2007161702A (ja) 水性吸入用医薬組成物
JP2002510653A (ja) 緩衝剤としてコハク酸を含有する注射可能なｉｇｆ処方物
EP1028748B1 (en) Compositions providing for increased igf-i solubility
JPH0565231A (ja) エリスロポエチンの持続性製剤
KR20230079305A (ko) 인슐린을 포함하는 초 장시간 지속형 약학 조성물
AU2003213511A1 (en) Stabilized Teriparatide Solutions
WO1998005358A1 (fr) Preparations pour injection a liberation prolongee, contenant du gabexate-mesylate
JPH0378848B2 (pt)

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed